Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Tagrisso significantly improves overall survival in the Phase III FLAURA trial for 1st-line EGFR-mutated non-small cell lung cancer
-
Lynparza Phase III PROfound trial in HRR* mutation-selected metastatic castration-resistant prostate cancer met primary endpoint
-
Forxiga label updated in the EU in type-2 diabetes
-
H1 2019 Results
-
Update on US regulatory decision for Farxiga in type-1 diabetes
-
Imfinzi granted US Orphan Drug Designation for small cell lung cancer
-
Forxiga receives positive EU CHMP opinion for DECLARE-TIMI 58 cardiovascular outcomes data
-
Fasenra receives positive EU CHMP opinion for self-administration and the new Fasenra pen, a pre-filled, single-use auto-injector
-
Imfinzi improves overall survival at interim analysis in the Phase III CASPIAN trial in 1st-line extensive-stage small cell lung cancer
-
Breztri Aerosphere (PT010) approved in Japan for patients with chronic obstructive pulmonary disease
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here